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Abstract
Purpose Kashin-Beck disease (KBD) is an endemic degen-
erative osteoarthritis associated with extracellular matrix
degradation. The aim of this investigation was to evaluate
the role of targeting genes in the pathogenesis of KBD and
primary osteoarthritis (OA) involved in extracellular matrix
degradation.
Methods Agilent 44 K human whole-genome oligonucle-
otide microarrays were used to detect the gene expression
in KBD and OA cartilage. The mRNA and protein expres-
sions of CSGalNAcT-1 and Hapln-1 in chondrocytes were
verified by reverse transcription polymerase chain reaction
(RT-PCR) and western blot, and their expression in carti-
lage were verified with immunocytochemical analysis.
Meanwhile, CSGalNAcT-1 and Hapln-1 protein levels in
the selenium intervention group of KBD with different
concentrations (0.25, 0.1and 0.05 μg/ml) were detected
by western blot.
Results CSGalNAcT-1 and Hapln-1 were down-regulated in
KBD and OA at both mRNA and protein levels, and were
increased in Se(Selenium) groups compared to KBD free-Se
group. However, Wnt 3a, β-catenin and Runx-2 were up-
regulated in OA and KBD at protein levels. Additionally,
immunohistochemical staining showed that CSGalNAcT-1
and Hapln-1 were reduced in all zones of KBD and OA
articular cartilage, but not significantly reduced in the up
zone of OA articular cartilage.
Conclusions The CSGalNAcT-1 and Hapln-1 were down-
regulated in both KBD and OA cartilage. CSGalNAcT-1
may be involved in the damage of articular cartilage of
KBD and OA by regulating Hapln-1 in the Wnt/β-catenin
signalling pathway. It was indicated that CSGalNAcT-1
and Hapln-1 may play important roles in the pathogenesis
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Introduction
Kashine Beck disease (KBD) is a chronic, endemic
osteochondropathy, which is mainly distributed in Asia,
including China, South Korea, Russia, etc. Osteoarthritis
(OA) is a chronic degenerative joint disease with increasing
prevalence with age. Compared to OA, KBD displays clas-
sic enlarged interphalangeal joints but not joint pain, stiff-
ness, limitation of motion in clinical manifestations, and
characteristic pathology changes with chondrocyte apopto-
sis and necrosis in deep zones of cartilage. Focal
chondronecrosis and the impaired endochondral ossification
in the deep zone of cartilage of KBD results in further
chronic deforming osteoarthrosis and impaired skeletal de-
velopment [1]. At present, there are three major environ-
mental hypotheses of KBD [2–4]: selenium deficiency, se-
rious cereal contamination by mycotoxin-producing fungi
and high humic acid levels in drinking water. OA, as the
most prevalent degenerative joint disease, causes chronic
joint pain and disability by destruction and loss of articular
cartilage. As the degenerated disease, necrosis and apoptosis
of chondrocytes and degradation of extracellular matrix
(ECM) in damaged articular cartilage have been observed
in both KBD and OA [5], although referred to different
pathogenesis.
Chondroitin sulfate N-acetylgalactosaminyl-transferase-1
(CSGalNAcT-1), an essential enzyme in chondroitin sul-
phate metabolism, participates in chondroitin sulphate
(CS) chain formation of aggrecan, and plays an important
role in degenerative extracellular matrix of cartilage. Recent
studies have also highlighted the key role of CSGalNAcT-1
in chondrogenesis at early developmental stages [6].
Additionally, in experimental animal models, the cartilage
of CSGalNAcT-1-null mice was significantly smaller than
that of wild-type mice, suggesting the importance of
CSGalNAcT-1 in endochondral ossification [7].
Although there are several studies about the biological
function of CSGalNAcT-1 in vivo and in vitro, it has not
been linked to human cartilage-like disease, such as KBD
and OA. Hyaluronan and proteoglycan link protein 1
(Hapln-1), also named cartilage link protein 1 (Crtl-1) or
link protein, is an important component of the cartilage
matrix [8–10]. It stabilises aggregation of aggrecan and
hyaluronic acid, two extracellular matrix components es-
sential for cartilage development [9]. The disruption of
Crtl-1 resulted in a severe chondrodysplasia [11].
However, the correlation between Hapln-1 with OA has
been rarely performed, and there are even no reports on
Hapln-1 in KBD. Therefore we investigated the differen-
tial expression of CSGalNAcT-1 and Hapln-1 among
KBD, OA, and normal cartilage.
In this study, we screened and identified the differentially
expressed genes (CSGalNAcT-1, Hapln-1, Wnt 3a, β-catenin
and Sox-9) in KBD and OA cartilage, to understand their
potential role in mechanism of disease.
Materials and methods
Target gene screening and CSGalNAcT gene network
Human glycosyltransferase related genes were screened from
CFG (Consortium for Functional Glycomics) and CAZY
database [12]. Differentially expressed glycosyltransferase
related genes between KBD and OA chondrocytes were
screened using Agilent 44 K human whole-genome oligonu-
cleotide microarrays of KBD and OA cartilage [13], the
selection criteria were defined as a more than two-fold differ-
ence in the level of expression (i.e., difference in up-regulated
expression more than two-fold, and difference in down-
regulated expression less than 0.5-fold) and further targeted
genic screening had been investigated through their biological
functions. The CSGalNAcT gene network was graphically
displayed which described the relationships between a subset
of genes and their neighbouring genes using IPA.
Tissue preparation and groups
Cartilage samples collected were divided into three
groups: (1) Normal control group: eight samples of artic-
ular cartilage were collected from individuals unaffected
with KBD from non-KBD areas; five males and three
females between 55 and 64 years old who had failed
surgery; (2) OA group: six samples of articular cartilage
were collected from hospitals of non-KBD areas; four
males and two females between 56 and 65 years old who
had accepted joint replacement surgery without KBD; and
(3) KBD group: six samples of articular cartilage were
collected from KBD diseased areas including four males
and two females aged from 49 to 63 years old who had
accepted joint replacement surgery. The patients with OA
were diagnosed as having OA according to the Western
Ontario and McMaster Universities OA Index of pain,
stiffness, function [14], and some clinical examination,
which allowed for exclusion of KBD and rheumatoid
arthritis (RA). Patients with KBD were diagnosed as hav-
ing grade II or III disease on the basis of the clinical
criteria for the diagnosis of KBD in China.
Cell culture
Articular cartilage was obtained from KBD, OA patients
and femoral head replacement for trauma as control sam-
ples. Samples were sequentially digested by trypsin (0.5%),
and type II collagenase (0.2%). Cells were seeded at the
density of 1.5×104cells per cm2 in DMEM/F12 with 10%
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FBS in 25 cm2 culture flasks and cultured until they reached
confluence. Primary cells of OA and control samples were
passaged in culture with 10% FBS. Primary cells of KBD
were passaged in culture using trypsinisation (0.02% tryp-
sin) and cultured for another 48 hours. Then the different
concentrations of selenium (0.25, 0.1 and 0.05 μg/ml) were
added and cultured for three weeks with every three days a
change of the medium.
Quantitative analysis of CSGalNAcT-1 transcripts in OA,
KBD and normal chondrocytes by real-time PCR
Total RNAwas isolated from chondrocytes using Trizol proto-
col. cDNA was generated using RevertAid™ First Strand
cDNA Synthesis Kit (Thermo Scientific Molecular Biology,
Canada) according to the manufacturer’s instructions. The for-
ward primer for CSGalNAcT-1 was 5′-GACTTCATCAATAT
AGGTGGGTTTGAT-3′, the reverse primer was 5′-GTCCG
TACCACTATGAGGTTGCT-3′ [15]. The forward primer
for Hapln-1 was 5′-AATGATGGTGCTCAGATTGC AA-3′,
the reverse primer, 5′-ACAGCGGTCATATCCGAGAATTT-
3′ [16]. Quantitative RT-PCR was performed using the FTC
3000 real-time PCR System (Funglyn Biotech Inc., Canada).
Relative quantification of mRNA expression was calculated
using the 2-ΔΔCt method, in which ΔΔCt=(Ctgene−
Ctβ)KBD/OA−(Ctgene−Ctβ)control. The relative amount of each
CSGalNAcT-1 and Hapln-1 were normalised to the amount of
β-actin transcript in the same cDNA. All assays were
performed in triplicate.
Immunohistochemistry
Cartilage slices (0.5–1 cm) were fixed with 4% parafor-
maldehyde for 24 hours after removal of the tissue and
decalcified in 3% ethylenediaminetetraocetic acid
(EDTA). The samples were dehydrated in a series of
alcohol, cleared in xylene, and embedded in paraffin
wax. Paraffin sections (4–5 μm) were cut, mounted on
slides, pretreated with 2% with 10% poly-l-lysine, and
stored at room temperature until used. Paraffin-embedded
sections were deparaffinised with xylene and then
rehydrated in graded ethanol. Endogenous peroxidase ac-
tivity was blocked by 3% H2O2 for 15 minutes at room
temperature. The method of 10 mol/L urea for 20 minutes
at 37 ° C and complex enzyme digesting for 20 minutes
was used for antigen retrieval. Then nonspecific binding
was blocked by normal goat serum. For the primary anti-
body, polyclonal rabbit anti-human primary antibodies
against CSGalNAcT-1 (1:50; ABGENT, San Diego, CA
92121, USA) and Hapln-1 (1:50; Abcam, UK) were used
at 4 ° C overnight. After incubation for 20 min at room
temperature with goat anti-rabbit IgG (Zhongshan
Goldenbridge Biotechnology Co., Ltd., Beijing, China),
the sections were reacted with 3, 3′-diaminobenzidine
(DAB) solution for three minutes and then were counter-
stained with hematoxylin for ten seconds.
Western blot analysis
Protein was extracted from chondrocytes using tissue pro-
tein extraction kit according to the manufacturer’s instruc-
tions. The concentration of total protein was quantified
using the NanoDrop ND-1000 (NanoDrop Technologies,
Wilmington, DE, USA). Twelve uL of total protein was
loaded per lane and electrophoresed in 12% SDS-PAGE
using a constant voltage of 80 V for two hours. Then the
proteins were transferred onto 0.45-nitrocellulose PVDF
membranes (Hybond-ECL, Amersham) at 350 mA for
90 minutes and blocked with 5% nonfat milk at room
temperature for two hours. The membranes were incubated
overnight at 4 °C with 1:500-diluted primary antibodies to
CSGalNAcT-1 (1:50; ABGENT, San Diego, CA 92121,
USA) and Hapln-1 (1:50; Abcam(HK)Ltd, UK), Wnt 3a
(rabbit polyclonal antibody, Cell Signalling), β-catenin
(mouse monoclonal antibody, Santa), Runx-2 (rabbit poly-
clonal antibody, Bioworld) and Sox-9 (rabbit polyclonal
anti-Hapln-1 antibody, Cell Signalling) in TBST containing
5% nonfat milk and β-actin (Mouse monoclonal anti-β-
actin antibody, ABGENT, USA). After being incubated with
anti-rabbit or anti-mouse IgG (1:4,000) and immunoreactive
proteins were visualised on a film with an enhanced chemi-
luminescence kit (NEN Life Science Products, Boston, MA,
USA). Quantification of band intensity was determined
using image software.
Statistical analysis
Statistical differences in expressions of protein between OA
and KBD were analysed statistically with SPSS 13.0 soft-
ware. Differences in mRNA levels for OA and KBD were
tested using the Student’s t test. Statistical significance was
accepted at P<0.05. The correlation of CSGalNAcT-1 and
Hapln-1 were tested using Spearman’s rank correlation.
Results
General findings screened by glycosyltransferase gene
and CSGalNAcT gene network
Fifteen up-regulated genes and ten down-regulated genes
were screened from 416 genes related to glycosyltransferase
using CFG (Consortium for Functional Glycomics) [12, 17],
CAZY and Agilent 44 K human whole-genome oligonucle-
otide microarrays for KBD and OA (Tables 1 and 2). The
CSGalNAcT gene network was graphically displayed which
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described potential relationships between a subset of genes
and their neighboring genes (Fig. 1).
Lower expression of CSGalNAcT-1 and Hapln-1 mRNA
in KBD and OA cartilages
CSGalNAcT-1 mRNA level was significantly lower in OA
cartilage than normal cartilage (P=0.037) using quantitative
real-time PCR; meanwhile, the expression of CSGalNAcT-1
was less in KBD than OA cartilage (P=0.014). Similarly,
Hapln-1 mRNA expression level was also regularly de-
creased in OA and KBD compared with normal cartilage
(P<0.0001, P=0.029, respectively) (Fig. 2).
The expression of CSGalNAcT-1 and Hapln-1
in all morphological zones of articular cartilage from KBD
and OA patients
In contrast to the control group (Fig. 3a,d,g; Fig. 4a,d,g),
CSGalNAcT-1 and Hapln-1 staining was remarkably re-
duced in the middle and deep zones of the OA group
articular cartilage (Fig. 3b,e,h; Fig. 4b,e,h), but was hardly
expressed in all morphological zones of KBD group articu-
lar cartilage (Fig. 3c,f,i; Fig. 4c,f,i).
The protein expressions of CSGalNAcT-1 and Hapln-1
were significantly reduced in all morphological zones of
articular cartilage from KBD and OA patients compared
Table 1 Selected list of genes
with higher expression in
Kashin-Beck disease (KBD)
than osteoarthritis (OA)
Function Public ID Gene symbol Differential fold change,
mean ± SEM
Cytokine/growth factor NM_000597 IGFBP2 3.51±2.52
Lipid metabolism NM_004315 ASAH1 17.35±15.03
Glycan biosynthesis and metabolism
Metabolism NM_003779 B4GALT3 2.86±1.08
Metabolism NM_015170 SULF1 14.28±13.25
Metabolism NM_020692 GALNTL1 25.53±16.87
Metabolism NM_020474 GALNT1 11.58±8.93
Metabolism NM_022087 GALNT11 25.43±14.17
Metabolism NM_022167 XYLT2 5.27±2.05
Metabolism NM_175856 CSS3 7.83±3.97
Cytoskeleton and cell movement NM_001614 ACTG1 29.09±13.13
Development process NM_004450 ERH 5.52±4.66
Activin and inhibin NM_002193 INHBB 5.65±4.08
Cytokine NM_002727 PRG1 33.04±18.24
Protein synthesis and modification NM_000993 RPL31 38.01±11.65
Oncogene related NM_002966 S100A10 4.84±2.36
Table 2 Selected list of genes
with lower expression in Kashin-
Beck disease (KBD) than osteo-
arthritis (OA)
Function Public ID Gene symbol Differential fold change,
mean ± SEM
Macrophage related NM_004864 GDF15 0.23±0.12
Aggrecan Metabolism
Miscellaneous AK098514 CSGALNACT 0.04±0.007
Metabolism NM_003033 ST3GAL1 0.04±0.008
Glucose metabolism NM_005566 LDHA 0.32±0.23
Oncogene related NM_001015049 BAG5 0.26±0.2
DNA modification NM_018371 ChGn 0.4±0.22
Cytokine NM_003278 CLEC3B 0.33±0.12
Cytokine/growth factor NM_000201 ICAM1 0.34±0.29
Lysosome related NM_005561 LAMP1 0.015±0.001
Extracellular matrix relate NM_001884 HAPLN1 0.44±0.13
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with the controls (t=3.556, 36.824, df=16, P=0.000, 0.016,
respectively). The CSGalNAcT-1 and Hapln-1 expressions
in articular cartilage from patients with KBD were weaker
than that of OA in the upper zone (t=13.895, 19.825, df=14,
P<0.0001), but showed no significance in the middle and
deep zone by t test (Table 3). Additionally, there were
correlations between CSGalNAcT-1 and Hapln-1 by analy-
sis using Spearman’s (r=0.937, P<0.0001).
Expression of CSGalNAcT-1, Hapln-1, Wnt 3a, β-
catenin and Runx-2 at protein levels in KBD and OA
cartilage and Se KBD group.
We performed Western blot analysis to determine the
protein levels of CSGalNAcT-1, Hapln-1, Wnt 3a, β-
catenin and Runx-2. As shown in Fig. 5, CSGalNAcT-1
and Hapln-1 were weakly expressed in OA compared with
normal cartilage, but more frequently overexpressed
compared with KBD cartilage. Wnt 3a, β-catenin and
Runx-2 were overexpressed in OA compared with normal
cartilage, but more weakly expressed compared with KBD
cartilage. Figure 5 also showed that CSGalNAcT-1 and
Hapln-1 protein expressions were the lowest in the KBD
free-Se group. There was no significant difference be-
tween the 0.25 μg/ml Se groups and 0.10 μg/ml Se group,
but they were higher than the 0.05 μg/ml Se group,
suggesting that Se increased CSGalNAcT-1, Hapln-1,
Wnt 3a, β-catenin and Runx-2 expression in human chon-
drocyte. Quantification of band intensity was determined
using image software (SensiCapture), and showed a de-
crease in CSGalNAcT-1 and Hapln-1 expressions com-
pared with normal cartilage, and Wnt 3a, β-catenin and
Runx-2 expressions were increased in OA and KBD com-
pared with normal cartilage; however, CSGalNAcT-1 and
Fig. 1 Chondrocyte gene network of CSGalNAcT-1 was classified as glycan biosynthesis and metabolism and functional pathway
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Hapln-1 expressions were increased in the selenium KBD
group compared with the KBD group; Wnt 3a, β-catenin
and Runx-2 expression were decreased in the selenium
KBD group compared with the KBD group.
Discussion
CSGalNAcT and Hapln-1 were selected as candidate genes
from 25 glycosyltransferases related genes. CSGalNAcT-1 is
a member of the glycosyltransferases family, and other genes
of this family include, CSS [12], CSGlcAT [6], and
CSGalNAcT-2 [13]. All of these enzymes participate in the
CS chain elongation, whereas CS chain initiation probably
involves only CSGalNAcT-1 and 2. Hapln-1, as a key link
protein of cartilage matrix, is essential for cartilage proteogly-
can aggregate formation. The network of CSGalNAcT graph-
ically described the relationships between a subset of genes
and their neighbouring genes using IPA to analyse the regu-
latory mechanism of CSGalNAcT. Recent studies showed that
the Wnt/β-catenin signalling pathway could elicit matrix ca-
tabolism and occur in the hypertrophic zone of the growth
plate in developing and growing long bones; activation or
increased activity of the Wnt/β-catenin signalling pathway
could play a causative role in joint diseases [14, 15, 17–19].
The changes of Wnt signalling may affect the balance of
matrix GAG and CS in content [16], and CSGalNAcT-1 plays
an important role in CS metabolism. Therefore, we speculated
CSGalNAcT-1 may participate in the pathogenesis of KBD
and OA by influencing theWnt/β-catenin signalling pathway.
Fig. 2 CSGalNAcT-1 and Hapln-1 mRNA expression in osteoarthritis
(OA) cartilage, Kashin-Beck disease (KBD) cartilage and normal car-
tilage. CSGalNAcT-1 and Hapln-1 mRNA levels reach statistical sig-
nificance. * Denotes significant difference at P<0.05
Fig 3 Comparison of
CSGalNAcT-1 expression in
the cartilage from osteoarthritis
(OA), Kashin-Beck disease
(KBD) and normal groups. a, b,
c Denote the upper of normal,
OA and KBD cartilage,
respectively. d, e, f Denote the
middle of normal, OA and
KBD cartilage, respectively. g,
h, i Denote the deep of normal,
OA and KBD cartilage,
respectively
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The mRNA expressions of CSGalNAcT-1 and Hapln-1
were significantly less in KBD and OA compared with normal
cartilage tissue by real-time PCR. Additionally, we found that
CSGalNAcT-1 and Hapln-1 protein levels in KBD and OA
cartilage and chondrocytic were also obviously reduced com-
pared with control groups by immunohistochemical staining
and western blot. It was consistent with previous studies that
Hapln-1 mRNA expression was downregulated in osteoar-
thritic cartilage [20], and CSGalNAcT-1 was highly expressed
in the developing cartilage. Moreover, Yumi et al. reported
that CSGalNAcT-1 was required for at least 50% of the total
CS synthesis to preserve normal cartilage development based
on histology of the epiphyses of E18.5 wild-type and
CSGalNAcT-1-null (−/−) mice [21]. Taken together,
CSGalNAcT-1 and Hapln-1 expression decreased at transcrip-
tional and translational levels in the evolution process of
cartilage degenerative disorders. We supposed that if
CSGalNAcT-1 and Hapln-1 changed in amount, cartilage
tissue may acquire pathological changes.
Although KBD and OA are chronic joint diseases with
similar clinical manifestations and cartilage lesions, including
cartilage and matrix degeneration, chondrocyte necrosis, and
apoptosis, they have different pathogenesis [22]; therefore,
there is an urgent need to better understand its pathogenesis
to enable the development of new management, treatment
strategies and new pathological diagnostic standards to distin-
guish between KBD and OA. In our study, CSGalNAcT-1 and
Hapln-1 mRNA and protein levels in chondrocytes from
patients with KBD were weaker than that of OA. Besides
changes in the quantitative amounts and components in the
degradation of cartilage, the increased proliferative activity of
chondrocytes is primarily featured in the upper cartilage
zones, because of proliferative factors from the synovial fluid
[23]. This is consistent with our immunohistochemical
staining (Figs. 3 and 4; Table 3). In KBD patients,
CSGalNAcT-1 and Hapln-1 expression were lower in the
upper zone of cartilage than in OA patients; however, there
were no significant differences in the middle and deep zones.
In OA pathological changes, besides the histological and
morphological changes seen in the articular cartilage, the
increased proliferative activity of chondrocytes is primarily
featured in the upper cartilage zones, because of proliferative
factors from the synovial fluid. In the KBD patients, Xiong [1]
Table 3 Percentage of chondrocyte staining for CSGalNAcT-1 and
Hapln-1 in articular cartilage and growth plate cartilage of Kashin-
Beck disease (KBD), osteoarthritis (OA) patients and normal cartilage
Groups n Upper zone Middle zone Deep zone
Positive (%) Positive (%) Positive (%)
CSGalNAcT-1
Normal group 8 100.0±0.0ab 100.0±0.0ab 100.0±0.0ab
OA group 8 93.7±4.3ac 42.8±8.2a 20.4±8.6a
KBD group 8 46.0±9.5bc 40.9±6.0b 17.1±5.5b
Hapln-1
Normal group 8 100.0±0.0ab 100.0±0.0ab 100.0±0.0ab
OA group 8 90.9±2.9ac 45.8±12.5a 23.3±5.4a
KBD group 8 44.6±9.2bc 33.3±8.2b 18.6±7.6b
a Normal groups vs OA group, P<0.01
b Normal groups vs KBD group, P<0.01
c OA group vs KBD group, P<0.01
Fig. 5 CSGalNAcT-1 and Hapln-1 protein level expression reduced in
osteoarthritis (OA) and Kashin-Beck disease (KBD) cartilage com-
pared with normal controls. Wnt 3a, β-catenin and Runx-2 level
expression increased in OA and KBD cartilage compared with normal
controls. A KBD free-Se group. B 0.25 μg/ml Se+KBD group.
C 0.10 μg/ml Se+KBD group. D 0.05 μg/ml Se+KBD group
Fig. 4 Comparison of Hapln-1 expression in the cartilage from oste-
oarthritis (OA), Kashin-Beck disease (KBD) and normal groups. a, b, c
Denote the upper of normal, OA and KBD cartilage, respectively. d, e,
f Denote the middle of normal, OA and KBD cartilage, respectively. g,
h, i Denote the deep of normal, OA and KBD cartilage, respectively
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found that the deep zone of focal chondronecrosis and the
impaired endochondral ossification results in further chronic
deforming osteoarthrosis and impaired skeletal development.
Taken together, we believe that it is better to understand the
pathogenesis of KBD and OA by determining the location of
protein expression of CSGalNAcT-1 and Hapln-1 in morpho-
logical zones.
KBD, an endemic osteoarthropathy, principally occurs in
childhood [24]. The many severe KBD patients also exhibited
decreased limb length and short stature due to the focal and
irregular closure of the growth plates [25]. CSGalNAcT-1 is
necessary glycosyltransferase for normal levels of endochon-
dral ossification. The decrease in themRNA and protein levels
of aggrecan and Hapln-1 in the ECM of Csgalnact1−/− carti-
lage, and Csgalnact1−/−mice exhibited slight dwarfism [7].
Dongxu et al. confirmed that Se deficiency does not cause
KBD, but is closely related [26]. In our study, we investigated
the effect of Se on the CSGalNAcT-1, Hapln-1, Wnt 3a, β-
catenin and Runx-2 expressions and confirmed the protective
effects of Se on the cartilage development through increasing
the expressions of CSGalNAcT-1 and Hapln-1. Our findings
suggested that the environmental factor of KBD areas may
affect the Wnt/β-catenin signalling pathway and further de-
crease the level of CSGalNAcT-1 expression and formation of
aggrecan and Hapln-1 of the ECM in the cartilage develop-
ment stage, to become one of the important factors of KBD
development.
There was positive correlation between CSGalNAcT-1
and Hapln-1 expressions by Spearman’s rank correlation in
our study. This is consistent with Takashi Sato’s conclusions
that aggrecan and Hapln-1 of the ECM are significantly
reduced in Csgalnact-1−/− cartilage in an experimental ani-
mal model [7]. Hapln-1 is a stable macromolecular structure
that induces compression resistance and shock absorption in
the joints. Cartilage-specific expression of the Hapln-1
transgene can completely avert perinatal mortality in
Hapln-1-null mice and can correct skeletal abnormalities
depending on dose [11]. Therefore, we supposed that
CSGalNAcT-1 could contribute to cartilage degenerative
disorders by targeting the Wnt/β-catenin signalling pathway
from environmental factors of KBD areas (Se deficiency).
Conclusions
The down-regulation of CSGalNAcT-1 and Hapln-1 was
identified in both KBD and OA cartilage. CSGalNAcT-1
may participate in the pathogenesis of KBD and OA by
targeting the Wnt/β-catenin signalling pathway from envi-
ronmental factors of KBD areas. It may provide a better
understanding of the molecular details in KBD pathogenesis
for future research in osteochondrosis.
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